• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 1077

Oat polar lipid extract

Intended Use: Intended for use as a source of oat phospholipids, an emulsifier, or as a partial substitute for other fats and oils in cakes, muffins and biscuits, margarine and margarine-like spreads, and chocolate at levels up to 1.0 g/100 g; white chocolate at levels up to 1.5 g/100 g; nut spreads and non-milk-based meal replacement beverages at levels up to 2.0 g/100 g; and coffee and tea whiteners at levels up to 3.0 g/100 g of finished food.
Basis: Scientific procedures
Notifier: Naturex
Notifier Address: Givaudan International SA
Kemptpark 50
8310 Kemptthal
Switzerland
GRAS Notice (releasable information): GRN 1077 with amendment (in PDF) (6.6 MB)
Date of closure: Jul 7, 2023
FDA's Letter: At the notifier's request, FDA ceased to evaluate this notice (in PDF) (164 kB)
-
-